We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Evotec Completes Squeeze-Out Process for DeveloGen

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Evotec AG has announced the completion of the squeeze-out process to acquire all of the remaining shares of DeveloGen AG from its minority shareholders. Evotec now is owner of 100% of the shares in DeveloGen.

The former minority shareholders of DeveloGen will receive a payment of €12.75 per share, summing up to approximately €180,000.

Evotec had acquired 99.4% of the shares in DeveloGen in 2010. Following this, Evotec initiated a squeeze-out process regarding the remaining 0.6% of shares, which were held by about 250 minority shareholders.

A General Meeting of the DeveloGen shareholders on 8 November 2011 voted in favour of the squeeze-out.

The price per DeveloGen share of €12.75 was approved by an expert appointed by the Hannover district court.

With the registration of the squeeze-out in the commercial register Evotec became the sole owner of DeveloGen AG which has been renamed to Evotec (Göttingen) AG.